Abstract
Cardiac conduction defects (CCD) are a group of serious and potentially life-threatening disorders. CCD belongs to a group of pathologies with an alteration of cardiac conduction through the atrioventricular (AV) node, the His-Purkinje system with right or left bundle branch block, and widening of QRS complexes. CCD can lead to complete atrioventricular block (AV block) and cause syncope and sudden death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life A prospective study. Circulation. 1995;92(3):442-449.
Balmer C, Fasnacht M, Rahn M, et al. Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy. Europace. 2002;4(4):345-349.
Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc Res. 2003;57(4):961-973.
Roden DM, Balser JR, George AL Jr, et al. Cardiac ion channels. Annu Rev Physiol. 2002;64:431-475.
Roden DM, George AL Jr. Structure and function of cardiac sodium and potassium channels. Am J Physiol. 1997;273(2 Pt 2):H511-H525.
Benson DW. Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol. 2004;280(2):934-939.
Lenegre J. The pathology of complete atrio-ventricular block. Prog Cardiovasc Dis. 1964;6:317-323.
Lev M, Kinare SG, Pick A. The pathogenesis of complete atrioventricular block. Prog Cardiovasc Dis. 1964;6:317-326.
Hanson EL, Jakobs PM, Keegan H, et al. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail. 2002;8:28-32.
Oropeza ES, Cadena CN. New phenotype of familial dilated cardiomyopathy and conduction disorders. Am Heart J. 2003;145:317-323.
Morgagni GB. De sedibus, et causis morborum per anatomen indagatis libri quinque. 2 volums. In 1.Venetis, typ. Remondiniana 1761.
Adams R. Cases of disease of the heart, accompanied with pathological observation. Dublin Hospital reports. 1827;4:353-453.
Stokes W. Observations on some cases of permanently slow pulse. Quat J Med Sci. 1846;2:73-85.
van den Heuvel GCJ. Die ziekte van Stokes-Adams en een geval van aangeboren hart blok. Groningen 1908.
Lev M, Kinare SG, Pick A. The pathogenesis of atrioventricular block in coronary disease. Circulation. 197;42:409-425.
Bharati S, Lev M, Dhingra RC, et al. Electrophysiologic and pathologic correlations in two cases of chronic second degree atrioventricular block with left bundle branch block. Circulation. 1975;52(2):221-229.
Lev M, Cuadros H, Paul MH. Interruption of the atrioventricular bundle with congenital atrioventricular block. Circulation. 1971;43(5):703-710.
Morquio L. Sur une maladie infantile et familiale caracterisee par des modifications permanentes du pouls, des attaques syncopales et epileptiformes et la mort subite. Arch Med Enfants. 1901;4:467-475.
Osler W. On the so-called Stokes-Adams disease. Lancet. 1903;II:516-524.
Fulton ZMK, Judson CF, Norris GW. Congenital heart block occurring in a father and two children, one an infant. Am J Med Sci. 1910;140:339-348.
Wallgren A, Winblad S. Congenital heart-block. Acta Paediat. 1937;20:175-204.
Wendkos MH. Familial congenital complete A-V heart blocks. Am Heart J. 1947;34:138-142.
Gazes PC, Culler RM, Taber E, et al. Congenital familial cardiac conduction defects. Circulation. 1965;32:32-34.
Combrink JMD, Snyman HW. Familial bundle branch block. Am Heart J. 1962;64:397-400.
Steenkamp WF. Familial trifascicular block. Am Heart J. 1972;84:758-760.
Brink AJ, Torrington M. Progressive familial heart block—two types. S Afr Med J. 1977;52:53-59.
Van der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive familial heart block. Part II. Clinical and ECG confirmation of progression-report on 4 cases. S Afr Med J. 1986;70(6):356-357.
Van der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive familial heart block (type I). A follow-up study after 10 years. S Afr Med J. 1988;73:275-276.
Stephan E. Hereditary bundle branch system defect: survey of a family with four affected generations. Am Heart J. 1978;95:89-95.
Stephan E, de Meeus A, Bouvagnet P. Hereditary bundle branch defect: right bundle branch blocks of different causes have different morphologic characteristics. Am Heart J. 1997;133:249-256.
Brink PA, Ferreira A, Moolman JC, et al. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation. 1995;91:1633-1640.
de Meeus A, Stephan E, Debrus S, et al. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res. 1995;77(4):735-740.
Kruse M, Schulze-Bahr E, Corfield V, et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest. 2009;119(9):2737-2744.
Hui Liu, Loubna EL ZEIN, Martin Kruse, et al. Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circulation: Cardiovascular Genetics 2010;3:374-385 Published online before print June 19, 2010, doi: 10.1161/CIRCGENETICS.109.930867
Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999;23:20-21.
Probst V, Kyndt F, Potet F, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol. 2003;41(4):643-652.
Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature. 2001;409:1043-1047.
Wang DW, Viswanathan PC, Balser JR, et al. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation. 2002;105:341-346.
Bezzina CR, Rook MB, Groenewegen WA, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res. 2003;92:159-168.
Niu DM, Hwang B, Hwang HW, et al. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a non-sense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. J Med Genet. 2006;43(10):817-821.
Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest. 2003;111(3):341-346.
Makita N, Sasaki K, Groenewegen WA, et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm. 2005;2(10):1128-1134.
McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004;110(15):2163-2167.
Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA. 2005;293(4):447-454.
Remme CA, Wilde AA, Bezzina CR. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med. 2008 Apr;18(3):78-87.
Watanabe H et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118:2260-2268.
Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 1999;34:181-190.
Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med. 2007;39:91-107. A comprehensive review of the known genetic mutations that have been shown to cause FDC.
Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005;45:969-981.
Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med. 1999;341:1715-1724.
van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med. 2005;83:79-83.
Gruenbaum Y, Goldman RD, Meyuhas R, et al. The nuclear lamina and its functions in the nucleus. Int Rev Cytol. 2006;226:1-62.
Shumaker DK, Kuczmarski ER, Goldman RD. The nucleoskeleton: lamins and actin are major players in essential nuclear functions. Curr Opin Cell Biol. 2003;15:358-366.
Meune C, van Berlo J, Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med. 2006;354:209-210.
Pease WE, Nordenberg A, Ladda RL. Genetic counselling in familial atrial septal defect with prolonged atrio-ventricular conduction. Circulation. 1976;53:759-762.
Schott J-J, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2–5. Science. 1998;281:108-111.
Watanabe Y, Benson DW, Yano S, Akagi T, Yoshino M, Murray JC. Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J Med Genet. 2002;39:807-811.
Hirayama-Yamada K, Kamisago M, Akimoto K, et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet. 2005;135A:47-52.
Gutierrez-Roelens I, De Roy L, Ovaert C, Sluysmans T, Devriendt K, Brunner HG, Vikkula M. A novel CSX/NKX2–5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Schott, JJ. (2011). Hereditary Cardiac Conduction Diseases. In: Baars, H., Doevendans, P., van der Smagt, J. (eds) Clinical Cardiogenetics. Springer, London. https://doi.org/10.1007/978-1-84996-471-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-84996-471-5_17
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-470-8
Online ISBN: 978-1-84996-471-5
eBook Packages: MedicineMedicine (R0)